CNR Institutional Research Information System

PISANO, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.612
NA - Nord America 1.700
EU - Europa 908
SA - Sud America 397
Continente sconosciuto - Info sul continente non disponibili 142
AF - Africa 39
OC - Oceania 6
Totale 5.804
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.604
SG - Singapore 1.007
CN - Cina 604
IT - Italia 428
BR - Brasile 314
HK - Hong Kong 264
VN - Vietnam 217
BD - Bangladesh 127
FR - Francia 119
KR - Corea 112
NL - Olanda 103
JP - Giappone 94
DE - Germania 51
IN - India 51
GB - Regno Unito 48
CA - Canada 43
FI - Finlandia 34
AT - Austria 31
AR - Argentina 27
CO - Colombia 23
MX - Messico 23
IL - Israele 22
ID - Indonesia 21
ZA - Sudafrica 16
IQ - Iraq 13
PL - Polonia 13
ES - Italia 12
IE - Irlanda 12
TR - Turchia 11
UA - Ucraina 11
EC - Ecuador 9
SA - Arabia Saudita 8
UZ - Uzbekistan 8
VE - Venezuela 8
MY - Malesia 7
PK - Pakistan 7
CZ - Repubblica Ceca 6
JM - Giamaica 6
PH - Filippine 6
SE - Svezia 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
MA - Marocco 5
PY - Paraguay 5
RU - Federazione Russa 5
AU - Australia 4
BE - Belgio 4
CL - Cile 4
KZ - Kazakistan 4
AL - Albania 3
CH - Svizzera 3
EE - Estonia 3
HN - Honduras 3
LV - Lettonia 3
SC - Seychelles 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
CR - Costa Rica 2
CU - Cuba 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GD - Grenada 2
GE - Georgia 2
GT - Guatemala 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
KH - Cambogia 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MM - Myanmar 1
MZ - Mozambico 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 5.660
Salva come PNG Salva come JPEG
Città #
Singapore 588
Santa Clara 311
Hong Kong 261
San Jose 254
Hefei 247
Ashburn 134
Seoul 108
Lauterbourg 100
Beijing 93
Ho Chi Minh City 80
Tokyo 74
Los Angeles 67
Hanoi 56
Dallas 52
Milan 45
New York 35
São Paulo 34
Cavallino 28
Rome 28
Boardman 26
Amsterdam 25
Vienna 25
Guangzhou 24
Buffalo 23
Cagliari 21
San Gregorio di Catania 21
Council Bluffs 20
Genoa 19
Frankfurt am Main 18
Helsinki 18
Bari 17
Minamishinagawa 15
Naples 15
Chicago 13
Sassari 13
Bengaluru 12
Brooklyn 12
Montreal 12
Rio de Janeiro 12
Sala Baganza 12
Dublin 11
Düsseldorf 11
Turku 11
Assemini 10
Da Nang 10
Orem 10
Warsaw 10
Brasília 9
Denver 9
Houston 9
Manchester 9
Mexico City 9
Phoenix 9
Bogotá 8
Florence 8
Hải Dương 8
Jakarta 8
Johannesburg 8
Las Vegas 8
Munich 8
Charlotte 7
Chennai 7
London 7
Porto Alegre 7
Tashkent 7
The Bronx 7
Toronto 7
Atlanta 6
Mumbai 6
Baghdad 5
Baltimore 5
Biên Hòa 5
Buenos Aires 5
Curitiba 5
Dhaka 5
Elk Grove Village 5
Haiphong 5
Hortolândia 5
Istanbul 5
Kingston 5
Lappeenranta 5
Madrid 5
Memphis 5
Nairobi 5
Newark 5
Queens 5
Salvador 5
San Francisco 5
Winnipeg 5
Belmont 4
Belo Horizonte 4
Bologna 4
Boston 4
Detroit 4
Guayaquil 4
Hyderabad 4
Ninh Bình 4
Orlando 4
Perugia 4
Philadelphia 4
Totale 3.356
Salva come PNG Salva come JPEG
Nome #
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 128
Inhibitory Effect of Curcumin-Inspired Derivatives on Tyrosinase Activity and Melanogenesis 115
Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma 95
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population 94
Antitumoral effects of Vanadium compounds in malignant melanoma cell lines 90
Il CSCC: aspetti distintivi della patologia 87
ANTIPROLIFERATIVE ACTIVITY OF VANADIUM COMPOUNDS: EFFECTS ON THE MAJOR MALIGNANT MELANOMA MOLECULAR PATHWAYS 86
Antioxidant, Antimicrobial, and Other Biological Properties of Pompia Juice 86
Germline and somatic NGS-based analysis on BRCA-related tumors 86
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 85
Michael Acceptor Bearing A Hydroxylated Biphenyl Structure As Molecular Core For New Compounds Against Malignant Melanoma Cells 83
Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia 83
Synthesis of Hydroxylated Biphenyls Derivatives Bearing an Alpha, Beta-Unsaturated Ketone as Lead Structure for the Development of New Drug Candidates Against Malignant Melanoma 81
Functionals interactions of the MAPK-ERK gene pathway in melanoma pathogenesis. 79
Liquid Biopsy in the Oncological Management of a Histologically Undiagnosed Lung Carcinoma: A Case Report 76
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 76
Attività anti-proliferativa e pro-apoptotica di bifenili derivati dall eugenolo e dall isoeugenolo su cellule tumorali di melanoma maligno. 75
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 73
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 73
Liquid biopsy in clinical oncology 73
Anticancer activity of two novel hydroxylated biphenyl compounds toward malignant melanoma cells 72
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population 69
COMPARATIVE ANALYSIS OF ENDOCANNABINOID SYSTEM GENE EXPRESSION ON METASTATIC VS PRIMITIVE MELANOMA CELL LINES. 69
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 69
Molecular Basis of open-angle glaucoma in Italy 68
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 68
Molecular landscape profile of melanoma 68
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 67
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research 66
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 64
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 63
Analoghi strutturali della curcumina come potenziali agenti antitumorali contro il melanoma maligno. 60
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial 60
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 59
In vitro and in vivo evaluation of the antitumour activity for a new curcumin-related compound in melanoma and neuroblastoma cells 57
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma 57
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 55
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 55
Liquid biopsy-driven Cetuximab rechallenge strategy in molecularly selected metastatic colorectal cancer patients 55
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 54
Antiproliferative activity of eugenol and curcumin related biphenyls on malignant melanoma cell lines 53
PROTEOMIC PROFILE MODIFICATIONS INDUCED IN MALIGNANT MELANOMA CELLS BY THE CURCUMIN ANALOGUE COMPOUND D6 52
"Proprietà Funzionali e Possibile Valorizzazione delle Foglie di Vitigni Endemici" 51
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 51
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 50
Functionalization of Hydroxylated Phenols and Biphenols Bearing an a,b-Unsaturated Keton as Lead Compound 50
In vitro activity of the avb3 integrin antagonist RGDechi-hCit on malignant melanoma cells 49
Polimorfismi del sistema renina-angiotensina in una popolazione del Nord Sardegna: associazione fra angiotensinogeno ed ipertensione arteriosa essenziale ad insorgenza precoce. 49
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 48
Preparation of new hydroxylated natural-like biphenyls and their antitumoral activity. 47
Caratterizzazione dei meccanismi d'azione coinvolti nell'attività antitumorale di composti del vanadio su cellule di melanoma maligno 47
Proteomic analysis in melanoma cell lines with different genotypes 44
Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer 44
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 44
BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling 43
Molecular changes induced by the curcumin biphenyl analogue D6 in melanoma cells 42
Microsatellite Analysis at 10q25-q26 in Sardinian Patients with Sporadic Endometrial Carcinoma:Identification of Specific Patterns of Genetic Alteration 42
Identification of candidate transcripts at chromosomes 10q25-q26 and 9p21 in endometrial cancer (EC) and malignant melanoma (MM). 41
Search for therapeutic response molecular markers in malignant melanoma through NGS: on the way to an anti-BRAF combination therapy. 40
DISSECTING MOLECULAR PATHWAYS INVOLVED IN THE ANTIPROLIFERATIVE EFFECTS OF VANADIUM COMPOUNDS IN A375 MALIGNANT MELANOMA CELL LINE. 40
Female Adnexal Tumors of probable Wolffian Origin (FATWO): a case series with next-generation sequencing mutation analysis 40
"Genomic instability of the human chromosome 10q25-q26 in patients with endometrial cancer". In New technologies for gynecologic and obstetric investigation. 4th Congress of the European society for gynecologic and obstetric investigation (1999) 40
Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells. 38
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 38
A refined physical and EST map spanning 7.4 Mb of 10q24, a region involved in neurological disorders 38
In vitro activity of the alfavbeta3 integrin antagonist RGDechi-hCit on malignant melanoma cells. 37
Analysis of the MAPK-ERK gene Pathway in primary and metastatic melanoma cell lines 37
Mechanism of pathogenicity in Salmonella abortusovis 37
A novel candidate gene in human endometrial cancer at chromosome 10q26 37
Molecular basis of open-angle glaucoma in Italy 36
Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma 36
The role of the TATA-binding protein in the assembly and function of the multisubunit yeast RNA polymerase III transcription factor, TFIIIB 36
Identification of a founder BRCA2 mutation in Sardinia 35
L'istituto di Chimica Biomolecolare a Sassari, Parte seconda 34
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial 34
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 34
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 34
Cloning, expression, and function of TFC5, the gene encoding the B'' component of the Saccharomyces cerevisiae RNA polymerase III transcription factor TFIIIB 33
"Transcription by RNA polimerase III" In Transcription: Mechanism and Regulation 32
2,2-dihydroxy-3,3-dimethoxy-5,5-dimethyl-6,6-dibromo-1,1-biphenyl: preparation, resolution, structure and biological activity. 32
4-Substituted-2-Methoxyphenol: Suitable Building Block to Prepare New Bioactive Natural-like Hydroxylated Biphenyls 32
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland 32
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 31
New curcumin analogues show enhanced antitumour activity in malignant melanoma cells 30
New curcumin analogues as potential antitumour agents against malignant melanoma. 30
How to treat BRAF mutant metastatic melanoma? 30
Caratterizzazione dei Meccanismi Molecolari Alla Base dell Attivita Antitumorale dell Analogo Struttuale della Curcumina D6. 29
Studio Biologico Cellulare e Molecolare di Nuovi Composti Bioattivi nel Melanoma Maligno 29
Genetic and epigenetic alterations of mismatch repair genes in endometrial and colorectal carcinomas 29
ASSESSMENT OF THE IN VITRO ACTIVITY OF RGDECHI-HCIT, alpha V beta3 INTEGRIN ANTAGONIST, ON MALIGNANT MELANOMA CELLS 28
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer 28
Protein expression changes induced in a malignant melanoma cell line by the curcumin analogue compound D6 28
BRCA1 and BRCA2 mutation analysis through an evaluation clinic program among Sardinian breast cancer patients. 28
A founder mutation in Sardinian brest cancer families detected by identity-by-descent method 28
Mutation analysis of HMLH1-HMSH2 genes among Sardinian patients with sporadic and familial colorectal cancer 28
Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer. 27
Natural derived hydroxylated byphenyl compounds as potential anti-melanoma agents. 27
Gene Expression Profile of Malignant Melanoma Cells Treated with a Structural Analogue of Curcumin (D6) 27
Profilo dell espressione genica in cellule di melanoma maligno trattate con un analogo strutturale della curcumina 26
New curcumin analogues present an enhanced anti-proliferative activity in malignant melanoma cells 26
Totale 5.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.271
article - articoli 12.467
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 786
Totale 32.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202479 0 0 0 0 0 0 0 0 4 2 51 22
2024/20251.849 21 5 105 80 321 104 58 114 79 110 467 385
2025/20263.226 190 272 282 389 547 153 445 222 206 205 170 145
2026/2027650 152 146 352 0 0 0 0 0 0 0 0 0
Totale 5.804